Hich are not fully investigated, needs to be avoided in the network. For example the 10 identified DMARDs may be combined in 45 distinct doubleTable 1. Study Characteristics and Risk of Bias Factors.Reference no. PARPR 1,4 1,4 1,four 1,four 0,9 1,1 1,7 0,5 12 12 12 200 240 240 six,0 eight,0 37,0 Larsen Larsen Larsen 1,3 1,3 115 99 20 Double Single MtGc Mt MtCs A A MtGc MtCsGc Double Single Double Double Triple 20 72 70 117 119 115 116 0,5 0,five two,five 1,eight 0,8 0,8 0,2 0,three 0,four 0,3 Larsen Larsen Sharp Sharp Sharp Sharp Sharp Sharp Larsen Larsen Larsen Larsen 47,0 31,five 28,five 6,2 two,7 1,9 1,9 17,0 11,0 4,7 6,0 7,0 eight,0 five,0 5,0 448 448 240 240 160 160 140 140 280 280 280 280 280 280 240 240 240 240 12 12 12 12 12 12 12 12 12 12 12 12 12 10 10 12 12 24 24 24 24 0,four 5,6 5,2 four,six 6,4 six,5 1,3 1,eight 1,0 1,five 2,3 6,4 3,4 1,five 1,four 1,four two,4 two,2 2,1 two,7 14,six 11,1 five,two 6,9 0,04 0,01 0,02 0,00 0,00 0,00 two,10 2,ten 2,20 3,25 two,15 0,00 0,00 0,09 0,09 0,09 0,06 0,04 0,05 0,00 0,00 0,62 0,28 0,04 0,01 0,00 0,00 0,82 0,82 0,82 0,82 0,03 A A A A A A A A A A A A A A A A B B A A A A A A B B A A A A A A B A B A B A A B A A C C C C C C Mt B A A AuGc B A A Au C C A MtGc C C A Mt Single Double Single A C A SuGc Double 54 A C A Su Single 49 A C A MtGc Double 43 A C A Mt Single 39 8,five two,eight B C A MtGc Double 32 13,0 B C A Mt Single 30 16,0 C C A SuGc Double 64 1,0 Sharp Larsen C C A Su Single 66 1,0 Sharp A C C AuCl Double 27 2,0 Larsen 31,2 A C C Au Single 32 2,0 Larsen 30,5 B C B CsCl Double 29 1,five Larsen 13,7 B C B CsMt Double 30 1,three Larsen 13,five 200 B C B Cs Single 30 1,3 Larsen 14,5 200 C C A MtCs Double 28 0,9 Sharp 1,1 280 C C A Mt Single 30 0,9 Sharp 1,two 280 12 C C C MtSu Double 49 0,9 Sharp 4,three 280 12 C C C Su Single 46 0,9 Sharp two,eight 280 12 C C C Mt Single 49 1,5 Sharp 3,eight 280 12 A C C InMt TNFiMt 119 0,five Sharp 2,0 280 12 A C C MtSuGc Triple 125 0,five Sharp two,0 280 12 A C C MtSu Double 110 0,5 Sharp 2,0 280 12 A C C Mt Single 115 0,5 Sharp 2,0 280 12 Yes Yes Yes Yes No No No Yes Yes No No No No No No No Yes Yes Yes Yes No No Yes Yes Yes Yes No No Yes Yes Yes YesSequence generation Incomplete Test outcome Sponsor drug Remedy group N_ (radiograph) Duration RA, Scoring years technique Duration of study, monthsRadioCongraphic cealed alloStudy Outcome secation blinding blinding quenceInitial radiographic scoreRadiographic score, MaxMean Dose GC mgStrategy adjust allowedDMARD inadequate response No No No No No No No No No No No No No No No No No No No No No No No No No No No No No No No NoPLOS One particular | plosone.Fmoc-His(Boc)-OH Chemical name org[3]AAC[3]AAC[3]AAC[3]AAC[17]BBA[17]BBA[17]BBA[18]BBC[18]BBC[19]BBC[19]BBC[19]BBC[20]BBA3 Combination Therapy in Rheumatoid Arthritis[20]BBA[21]AAA[21]AAA[22]BBA[22]BBA[23]ABC[23]ABC[24]BAA[24]BAA[25]ABC[25]ABC[26]BBA[26]BBA[27]ABA[27]ABA[28]AAA[28]AAA[28]AAA[28]AAATable 1.DL-dithiothreitol structure Cont.PMID:23539298 Reference no. PARPR 7,1 six,7 7,6 6,7 6,3 1,2 1,four 6,0 13 12 12 448 448 280 79,0 eight,3 eight,8 Sharp Sharp Sharp 11,0 6,2 393 127 246 Single ABAMt Mt AbMt Mt C A RtMt Mt Single ABAMt Single CD20iMt Single 195 391 223 218 184 273 15 six,1 five,six 6,1 8,9 eight,5 0,5 0,5 11,six 12,0 0,7 Sharp Sharp Sharp Sharp Sharp Sharp Sharp Sharp Sharp Sharp Sharp Sharp 13,6 11,0 37,2 41,4 20,0 20,0 23,1 19,0 21,eight 21,7 four,8 five,4 46,two 46,two 24 280 280 280 230 230 230 230 440 440 280 280 145 145 145 145 145 145 448 12 12 12 12 12 12 12 12 12 12 12 12 six six 12 12 12 12 12 12 22 two,4 0,six 0,5 1,four 1,6 2,7 2,8 3,three three,9 7,4 6,eight 1,5 1,6 0,7 0,7 1,5 1,1 1,7 1,eight 6,6 7,four 2,7 2,7 7,7 1,50 1,50 1,15 four,08 three,59 5,14 0,27 0,27 three,20 three,10 2,50 two,45 3,20 three,15 1,90 1,85 two,27 two,40 2,71.